Titre : Nodules pulmonaires multiples

Nodules pulmonaires multiples : Questions médicales fréquentes

Termes MeSH sélectionnés :

RNA, Long Noncoding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nodules pulmonaires multiples : Questions médicales les plus fréquentes", "headline": "Nodules pulmonaires multiples : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nodules pulmonaires multiples : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nodules pulmonaires multiples" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs du poumon", "url": "https://questionsmedicales.fr/mesh/D008175", "about": { "@type": "MedicalCondition", "name": "Tumeurs du poumon", "code": { "@type": "MedicalCode", "code": "D008175", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.520" } } }, "about": { "@type": "MedicalCondition", "name": "Nodules pulmonaires multiples", "alternateName": "Multiple Pulmonary Nodules", "code": { "@type": "MedicalCode", "code": "D055613", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Y L Gao", "url": "https://questionsmedicales.fr/author/Y%20L%20Gao", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China." } }, { "@type": "Person", "name": "R E Feng", "url": "https://questionsmedicales.fr/author/R%20E%20Feng", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China." } }, { "@type": "Person", "name": "Kazuhiko Morikawa", "url": "https://questionsmedicales.fr/author/Kazuhiko%20Morikawa", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } }, { "@type": "Person", "name": "Shigeki Misumi", "url": "https://questionsmedicales.fr/author/Shigeki%20Misumi", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } }, { "@type": "Person", "name": "Taiki Fukuda", "url": "https://questionsmedicales.fr/author/Taiki%20Fukuda", "affiliation": { "@type": "Organization", "name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37852142", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinsp.2023.100289" } }, { "@type": "ScholarlyArticle", "name": "Association of long noncoding RNA GAS5 gene polymorphism with progression of diabetic kidney disease.", "datePublished": "2024-08-13", "url": "https://questionsmedicales.fr/article/39239549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7150/ijms.99545" } }, { "@type": "ScholarlyArticle", "name": "Whole transcriptome analysis of long noncoding RNA in beryllium sulfate-treated 16HBE cells.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35679967", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.taap.2022.116097" } }, { "@type": "ScholarlyArticle", "name": "A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36490353", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18632/aging.204426" } }, { "@type": "ScholarlyArticle", "name": "A Long Noncoding RNA Derived from lncRNA-mRNA Networks Modulates Seed Vigor.", "datePublished": "2022-08-22", "url": "https://questionsmedicales.fr/article/36012737", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23169472" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012142" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du poumon", "item": "https://questionsmedicales.fr/mesh/D008175" }, { "@type": "ListItem", "position": 5, "name": "Nodules pulmonaires multiples", "item": "https://questionsmedicales.fr/mesh/D055613" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nodules pulmonaires multiples - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nodules pulmonaires multiples", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nodules pulmonaires multiples", "description": "Comment sont détectés les nodules pulmonaires multiples ?\nQuels examens complémentaires sont nécessaires ?\nQuels critères évaluent la malignité des nodules ?\nLes antécédents médicaux influencent-ils le diagnostic ?\nQuelle est l'importance du suivi des nodules ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nodules pulmonaires multiples", "description": "Quels sont les symptômes des nodules pulmonaires multiples ?\nLes nodules peuvent-ils causer des infections ?\nLes symptômes varient-ils selon l'étiologie ?\nPeut-on avoir des symptômes sans nodules visibles ?\nLes symptômes sont-ils toujours graves ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nodules pulmonaires multiples", "description": "Comment prévenir les nodules pulmonaires ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle le risque ?\nLe contrôle des maladies respiratoires aide-t-il ?\nLes vaccinations sont-elles utiles ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nodules pulmonaires multiples", "description": "Quel traitement pour les nodules bénins ?\nComment traite-t-on les nodules malins ?\nLes traitements varient-ils selon la taille des nodules ?\nY a-t-il des traitements expérimentaux ?\nLe suivi post-traitement est-il important ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nodules pulmonaires multiples", "description": "Quelles complications peuvent survenir ?\nLes nodules peuvent-ils causer des problèmes respiratoires ?\nY a-t-il un risque de métastases ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nodules pulmonaires multiples", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nL'exposition professionnelle joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment sont détectés les nodules pulmonaires multiples ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent détectés par radiographie ou tomodensitométrie (TDM)." } }, { "@type": "Question", "name": "Quels examens complémentaires sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie ou une imagerie par résonance magnétique (IRM) peut être nécessaire." } }, { "@type": "Question", "name": "Quels critères évaluent la malignité des nodules ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La taille, la forme, la calcification et l'évolution des nodules sont évaluées." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de tabagisme augmentent le risque de malignité." } }, { "@type": "Question", "name": "Quelle est l'importance du suivi des nodules ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le suivi permet de surveiller l'évolution des nodules et d'identifier des changements." } }, { "@type": "Question", "name": "Quels sont les symptômes des nodules pulmonaires multiples ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Souvent asymptomatiques, ils peuvent causer toux, douleur thoracique ou dyspnée." } }, { "@type": "Question", "name": "Les nodules peuvent-ils causer des infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections pulmonaires peuvent survenir en raison de l'inflammation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'étiologie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer selon qu'ils sont bénins ou malins." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans nodules visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent exister sans nodules détectables par imagerie." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours graves ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, beaucoup de cas sont bénins et asymptomatiques, nécessitant juste un suivi." } }, { "@type": "Question", "name": "Comment prévenir les nodules pulmonaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et les expositions environnementales nocives aide à prévenir." } }, { "@type": "Question", "name": "Les dépistages réguliers sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dépistages réguliers sont conseillés pour les personnes à risque élevé." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut réduire le risque de cancer pulmonaire." } }, { "@type": "Question", "name": "Le contrôle des maladies respiratoires aide-t-il ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, contrôler des maladies comme l'asthme peut réduire le risque de complications." } }, { "@type": "Question", "name": "Les vaccinations sont-elles utiles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre la grippe et le pneumocoque peuvent prévenir des infections." } }, { "@type": "Question", "name": "Quel traitement pour les nodules bénins ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les nodules bénins nécessitent souvent aucun traitement, juste une surveillance." } }, { "@type": "Question", "name": "Comment traite-t-on les nodules malins ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les nodules malins peuvent nécessiter chirurgie, chimiothérapie ou radiothérapie." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la taille des nodules ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la taille et la croissance des nodules influencent le choix du traitement." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux comme l'immunothérapie sont en cours d'évaluation." } }, { "@type": "Question", "name": "Le suivi post-traitement est-il important ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le suivi est crucial pour détecter toute récidive ou complication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'infection, l'hémorragie ou la progression vers le cancer." } }, { "@type": "Question", "name": "Les nodules peuvent-ils causer des problèmes respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nodules volumineux peuvent entraîner des difficultés respiratoires." } }, { "@type": "Question", "name": "Y a-t-il un risque de métastases ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nodules malins peuvent se propager à d'autres organes par métastases." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares, surtout si les nodules sont surveillés correctement." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion dépend de la nature de la complication et peut nécessiter un traitement spécifique." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des agents cancérigènes et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de nodules pulmonaires augmente avec l'âge." } }, { "@type": "Question", "name": "Les antécédents de cancer augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de cancer augmente le risque de développer des nodules." } }, { "@type": "Question", "name": "L'exposition professionnelle joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des expositions à l'amiante ou à d'autres substances toxiques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina.

Stable angina develops during physical activity or stress, and it is typically an aspect of Coronary Heart Disease (CHD) that can lead to arrhythmia, heart failure and even sudden death. ANRIL, an Ant... The authors enrolled 62 patients with myocardial infarction and 59 with stable angina before primary percutaneous coronary intervention, as well as 48 healthy volunteers. Their peripheral blood was co... The data showed that ANRIL is a better diagnostic indicator than cardiac troponin I in patients with stable angina and that the levels of ANRIL are higher in patients with stable angina than those wit... The levels of ANRIL in peripheral plasma could be used as a good biomarker for stable angina....

The association between long noncoding RNA ABHD11-AS1 and malignancy prognosis: a meta-analysis.

Accumulating evidence has highlighted that lncRNA ABHD11-AS1 plays an essential role in tumorigenesis and is expected to become a new predictive biomarker and ideal target for cancer therapy, whereas ... Eight databases were comprehensively screened for relevant articles on January 1, 2024. The significance of ABHD11-AS1 in malignancies was determined by odds ratios (ORs) or hazard ratios (HRs) with c... Fourteen clinical studies comprising eight kinds of malignancies and 1215 malignancy cases were enrolled into this meta-analysis. The pooled results showed that increased ABHD11-AS1 expression was rem... Current evidence supports the association of elevated ABHD11-AS1 expression with poor prognosis. Thereby, ABHD11-AS1 may be considered as a promising biomarker to screen cancer and predict malignancy ...

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia.

Optimized strategies for risk classification are essential to tailor therapy for patients with biologically distinctive disease. Risk classification in pediatric acute myeloid leukemia (pAML) relies o... To identify lncRNA transcripts associated with outcomes, we evaluated the annotated lncRNA landscape by transcript sequencing of 1,298 pediatric and 96 adult AML specimens. Upregulated lncRNAs identif... Training set cases with positive lncScores had 5-year EFS and overall survival rates of 26.7% and 42.7%, respectively, compared with 56.9% and 76.3% with negative lncScores (hazard ratio, 2.48 and 3.1... Inclusion of the lncScore enhances predictive power of traditional cytogenetic and mutation-defined stratification in pAML with potential, as a single assay, to replace these complex stratification sc...